Search results for: Maria Lowe
Filter search results
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
1 March 2019
…is that PCTs operating efficiently in a PBC tend to have lower rates of mortality, and for most disease areas, the lower the mortality, the harder it is to achieve…
Setting the Right Discount Rate for HTA in the Slovak Republic
21 May 2023
…we have formulated seven recommendations to the relevant departments of the Slovak government, and we summarise the four most relevant ones below. Lower the discount rate for use in reference…
Around The World in HTAs: The Netherlands – 5 Routes for New Tech
24 May 2023
…top of the mandatory deductible, in exchange for a lower monthly premium. For more details, please see State of Health in the EU: The Netherlands, Country Health Profile 2021. Assessment…
Around The World in HTAs: The Slovak Republic – Valuing the Future
13 September 2023
…is used. The discount rate currently required for health-related costs and benefits in pharmacoeconomic analysis in the Slovak Republic is 5% per year. Most other countries use a lower discount…
Navigating the Intersection of Healthcare and Environmental Sustainability: ISPOR Europe round-up on the inclusion of environmental impact in HTA
17 January 2024
…by lower-income individuals with lower health. Therefore, the wealth-health gradient could potentially be exacerbated through a more environmentally-centred HTA process, raising equity concerns. Consideration must therefore be given to distributional…
Inequalities in Dementia: Unveiling the Evidence and Forging a Path Towards Greater Understanding
26 June 2024
…admissions, inclusion in clinical trials, and drug prescribing. For example, diagnosis rates are between 5 and 8 percentage points lower in rural areas, with this gap increasing since 2020. Inequalities…
Pricing Variations Within and Across Countries: Gauging Efficiency
25 February 2014
…from retail pharmacies or via tendered procurement by non-government organizations. The study shows that drugs are least affordable relative to income in the lowest income countries and that relatively high…
A Market-based International Reference Price Index: Solution or Contradiction?
13 September 2019
…assurance that they are not overpaying for drugs relative to ‘similar’ countries. This latter strategy involves finding countries that are regarded as comparable, as opposed to just having lower prices….
Are Discount Rates Used in UK Vaccine Economic Evaluations Jeopardising Investment in Immunisation Programmes?
4 August 2020
…Netherlands and Poland apply differential discounting, where effects are discounted at a lower rate than costs, in response to philosophical and ethical objections to equal discounting based on the grounds…